PA-20-070 Integrating Patient-Reported Outcomes into Routine Primary Care: Monitoring Asthma Between Visits
PA-20-070 Integrating Patient-Reported Outcomes into Routine Primary Care: Monitoring Asthma Between Visits
批准号:
10175400
负责人:
Robert Samuel Rudin
金额:
$46.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2023-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The COVID-19 pandemic presents an unprecedented risk for the 25+ million individuals in the United States
who have asthma. Patients with chronic conditions such as asthma are more likely to have worse clinical
outcomes due the respiratory complications of COVID-19. Furthermore, the risk of COVID-19 related ED visits
and hospitalization is likely higher for patients with more severe asthma, minorities, and those of lower
socioeconomic status. As routine care of chronic disease is declining and maintenance medications are
unfilled, asthma patients are at even greater risk of exacerbations. It is widely established that good asthma
control can help prevent asthma exacerbations and current clinical guidelines recommend frequent monitoring
of asthma control in the ambulatory setting, but useful tools and practice models for symptom monitoring are
unavailable. In prior work, we developed and tested a simple mobile health (mHealth) app that can be installed
on patients' smartphones to track and self-report asthma symptoms using patient-reported outcomes (PRO)
between visits, and a practice model for clinics to monitor the patient-reported symptoms as part of routine
care. Based on the success of our feasibility study, we are currently scaling and spreading this intervention to
primary care clinics that serves a diverse population, including Spanish-speaking and low health literacy
patients. We are rigorously evaluating the effect of our clinically-integrated mHealth intervention in a
randomized controlled trial which is soon to begin. In this supplement to our current project, we will make three
enhancements to maximize health systems' and healthcare professionals' ability to respond to COVID-19.
First, we will enhancement the mHealth app with a COVID-19 symptom screener and relevant educational
materials. Second, we will use quantitative and qualitative methods to identify best practices, barriers, and
facilitators for recruiting patients to our home monitoring intervention during the pandemic. Finally, we will
develop and validate a predictive model to identify asthma patients who may benefit the most from our
intervention, using data available from the electronic health record (EHR). Identifying, recruiting, and safely
monitoring high-risk patients who could potentially utilize acute and critical care resources during the COVID-
19 pandemic are critical aspects of the healthcare system response. Our work will demonstrate how healthcare
systems can use data-driven approaches to identify patients at risk for poor outcomes who would preferentially
benefit from routine and remote monitoring of PROs via a clinically integrated digital interventions. The
knowledge gained from these supplemental aims will provide a clearer understanding of how health systems
might use health IT to keep the patients with chronic conditions, such as asthma, safe by improving
compliance with guidelines. Doing so will not only mitigate the health effects of COVID-19 in this population,
but also minimize the strain on acute and critical care capacity in future surges.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Assessing Equitable Recruitment in a Digital Health Trial for Asthma.
评估哮喘数字健康试验中的公平招募。
DOI:
10.1055/a-2090-5745
发表时间:
2023
期刊:
Applied clinical informatics
影响因子:
2.9
作者:
[Plombon,Savanna, SRudin,Robert, SulcaFlores,Jorge, Goolkasian,Gillian, Sousa,Jessica, Rodriguez,Jorge, Lipsitz,Stuart, Foer,Dinah, KDalal,Anuj]
通讯作者:
KDalal,Anuj
Toward an asthma patient-reported outcome measure for use in digital remote monitoring.
制定用于数字远程监测的哮喘患者报告的结果测量。
DOI:
10.1080/02770903.2021.1955378
发表时间:
2022
期刊:
The Journal of asthma : official journal of the Association for the Care of Asthma
影响因子:
--
作者:
[Rudin,RobertS, Qureshi,Nabeel, Foer,Dinah, Dalal,AnujK, Edelen,MariaO]
通讯作者:
Edelen,MariaO
Using mHealth and Patient-reported Outcomes to Deliver Evidence-based Asthma Care
-
批准号:9061566
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2015
-
负责人:Robert Samuel Rudin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CDC20-HDAC6-POLD1轴调控肺腺癌免疫微环境的机制研究
-
批准号:2026JJ80369
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡智
-
依托单位:
CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
-
批准号:2026JJ50313
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡希恒
-
依托单位:
USP20调控泛素化修饰介导微卫星稳定型结直肠癌免疫逃逸的机制研究
-
批准号:JCZRLH202600106
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
巴多昔芬通过重编程肿瘤相关巨噬细胞抑制CCL20介导的Treg募集并增敏乳腺癌免疫治疗的机制研究
-
批准号:JCZRQNB202600315
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IFT20 抑制肝星状细胞活化并诱导其凋亡的机制研究
-
批准号:2026JJ82074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:金富昌
-
依托单位:
新型可降解聚酯P20-2C联合利福平根除关节假体表面细菌生物膜的机制与应用研究
-
批准号:2026JJ82609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱怡
-
依托单位:
CL-20共晶/Al纳米复合炸药热分解-燃烧反应机理研究
-
批准号:JCZRLH202601722
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
SFRT激活新型STING调控因子协同CD3/CD20双抗治疗RR DLBCL的机制研究
-
批准号:JCZRLH202600672
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
亚20nm FinFET工艺下SRAM单粒子翻转机制及抗辐照加固关键技术研究
-
批准号:2026JJ60232
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:喻国芳
-
依托单位:
合肥长安燃油泵及支架总成1106100-DS20的研发及应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:冯国雄
-
依托单位: